Mohidin Barazi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mohidin Barazi has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Abdul Rahman R. Barakeh
College of Medicine, Alfaisal University College of Medicine, Riyadh, SAU
1 shared publication- Abdulrahman Taftafa
College of Medicine, Alfaisal University College of Medicine, Riyadh, SAU
1 shared publication - Feras Jazaeri
College of Medicine, Alfaisal University College of Medicine, Riyadh, SAU
1 shared publication Henry I Zaleski
Houston Methodist Hosp, Hematol & Oncol, Houston, TX 77030 USA
1 shared publication- Hussam Al Hennawi
Department of Internal Medicine, Jefferson Abington Hospital, Abington, Pennsylvania, USA
1 shared publication - Mohamad Bakir
College of Medicine, Alfaisal University, Riyadh, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 4 February 2022
- Published by Springer Nature in Cureus
- Vol. 14 (2) , e21909
Acquired Hemophilia A Post-COVID-19 Vaccination: A Case Report and Review
Acquired hemophilia A (AHA) is an inhibitory coagulopathy that represents a rare variant of hemorrhagic syndromes. We present a case of idiopathic AHA in a 75-year-old male patient with a cutaneous hematoma that could be attributed to a recent COVID-19 vaccination. The aim of this report is to raise awareness of a possible association between AHA and COVID-19 vaccination and to review similar reported cases and management plans to prevent the development of possible morbidity and debilitating complications. This case illustrates an exceptionally rare side effect of the COVID-19 vaccination. The advantages of obtaining the COVID-19 vaccine outweigh the risks.
- 4 February 2022
- Published by Springer Nature in Cureus
- Vol. 14 (2) , e21909
Open AccessAcquired Hemophilia A Post-COVID-19 Vaccination: A Case Report and Review
Acquired hemophilia A (AHA) is an inhibitory coagulopathy that represents a rare variant of hemorrhagic syndromes. We present a case of idiopathic AHA in a 75-year-old male patient with a cutaneous hematoma that could be attributed to a recent COVID-19 vaccination. The aim of this report is to raise awareness of a possible association between AHA and COVID-19 vaccination and to review similar reported cases and management plans to prevent the development of possible morbidity and debilitating complications. This case illustrates an exceptionally rare side effect of the COVID-19 vaccination. The advantages of obtaining the COVID-19 vaccine outweigh the risks.